Luisa L. Villa

Research interests

Publications

• ICTV Virus Taxonomy Profile: Papillomaviridae

  Journal of General Virology · 2018 · https://doi.org/10.1099/jgv.0.001105

• Planning cancer control in Latin America and the Caribbean

  The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70048-2

• Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

  JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djp534

• The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

  The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/597307

• The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

  The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/597309

• A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

  Cancer Prevention Research · 2009 · https://doi.org/10.1158/1940-6207.capr-09-0031

• An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

  Vaccine · 2008 · https://doi.org/10.1016/j.vaccine.2008.06.002

• Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

  Vaccine · 2007 · https://doi.org/10.1016/j.vaccine.2007.03.049

• Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

  Vaccine · 2006 · https://doi.org/10.1016/j.vaccine.2006.05.026

• Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

  Vaccine · 2006 · https://doi.org/10.1016/j.vaccine.2006.04.068

• Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia

  Cancer Epidemiology Biomarkers & Prevention · 2006 · https://doi.org/10.1158/1055-9965.epi-06-0129

• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

  British Journal of Cancer · 2006 · https://doi.org/10.1038/sj.bjc.6603469

• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

  The Lancet Oncology · 2005 · https://doi.org/10.1016/s1470-2045(05)70101-7

• Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia

  Journal of General Virology · 2000 · https://doi.org/10.1099/0022-1317-81-12-2959

• Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer

  JNCI Journal of the National Cancer Institute · 1999 · https://doi.org/10.1093/jnci/91.6.506

• Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

  The Journal of Infectious Diseases · 1999 · https://doi.org/10.1086/315086

Current projects

No projects listed.